BACKGROUND: Polymorphic variation at the 5p15.33 (TERT-CLPTM1L) locus is associated with the risk of many cancers but a relationship with colorectal cancer (CRC) risk has yet to be defined.
METHODS: We used data from six genome-wide association studies (GWAS) of CRC, linkage disequilibrium mapping and imputation, to examine the relationship between 73 single-nucleotide polymorphisms at 5p15.33 and CRC risk in detail.
RESULTS: rs2736100, which localises to intron 2 of TERT, provided the strongest evidence of an association with CRC (P - 2.28 x 10(-4)). The association was also shown in an independent series of 10 047 CRC cases and 6918 controls (P - 0.02). A meta-analysis of all seven studies (totalling 16 039 cases, 16 430 controls) provided increased evidence of association (P = 2.49 x 10(-5); per allele odds ratio = 1.07). The association of rs2736100 on CRC risk was shown to be independent of 15 low-penetrance variants previously identified.
CONCLUSION: The rs2736100 association demonstrates an influence of variation at 5p15.33 on CRC risk and further evidence that the 5p15.33 (TERT-CLPTM1L) locus has pleiotropic effects (reflecting generic or lineage-specific effects) on cancer risk.
- GENOME-WIDE ASSOCIATION
- TERT-CLPTM1L LOCUS
- SUSCEPTIBILITY LOCI
- colorectal cancer